A direct comparison of effect sizes from the clinical global impression‐improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Human psychopharmacology

• Publication date

  2009-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/hup.989PMID 18980264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.

  2007cited by this paper
• Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder

  2005cited by this paper
• Escitalopram in the treatment of social anxiety disorder

  2005cited by this paper
• Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

  2005cited by this paper
• Controlled-release paroxetine in the treatment of patients with social anxiety disorder.

  2004influential reference
• Efficacy and tolerability of escitalopram in 12‐ and 24‐week treatment of social anxiety disorder: Randomised, double‐blind, placebo‐controlled, fixed‐dose study

  2004influential reference
• Fluvoxamine-Controlled Release Formulation for the Treatment of Generalized Social Anxiety Disorder

  2004cited by this paper
• Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

  2004cited by this paper
• Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions

  2004cited by this paper
• Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2004cited by this paper
• Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial.

  2004cited by this paper
• Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.

  2004cited by this paper
• A self-report questionnaire for measuring separation anxiety in adulthood.

  2003cited by this paper
• Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

  2003cited by this paper
• A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder

  2003cited by this paper
• Fluoxetine in Social Phobia: A Double-Blind, Placebo-Controlled Pilot Study

  2002influential reference
• Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

  2002cited by this paper
• A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

  2002influential reference
• Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

  2001influential reference
• Paroxetine in social phobia/social anxiety disorder

  2000influential reference
• Psychometric properties of the Liebowitz Social Anxiety Scale

  1999influential reference
• Paroxetine in social anxiety disorder: a randomized placebo‐controlled study

  1999cited by this paper
• Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

  1999influential reference
• Paroxetine in social phobia/social anxiety disorder

  1999cited by this paper
• Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

  1998cited by this paper
• The Brief Social Phobia Scale: a psychometric evaluation

  1997influential reference
• The measurement of disability.

  1996cited by this paper
• The measurement of disability

  1996cited by this paper
• A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.

  1993cited by this paper
• "Clinical Global Impressions"(ECDEU): Some Critical Comments

  1992cited by this paper
• Statistical Methods for Meta-Analysis

  1987cited by this paper
• The Anxiety Disease

  1984cited by this paper
• Normal likelihoods and their relation to large sample theory of estimation

  1973cited by this paper
• Measurement of social-evaluative anxiety.

  1969influential reference

• Can Non-specific Blood Inflammatory Biomarkers Predict Recovery in Acute Transient Psychotic Disorder? A Prospective Observational Study.

  2025cites this paper
• Delta-Beta Coupling in Adolescents with Depression: A Preliminary Examination of Associations with Age, Symptoms, and Treatment Outcomes.

  2024cites this paper
• Objective sleep duration and response to combined pharmacotherapy and cognitive behavioral insomnia therapy among patients with comorbid depression and insomnia: a report from the TRIAD study

  2023cites this paper
• Binge-eating adolescent treatment (BEAT) – findings from a pilot study on effects and acceptance of a blended treatment program for youth with loss of control eating

  2023cites this paper
• The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder

  2023cites this paper
• Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials

  2023cites this paper
• ADHD and Psychopathy in Adolescent Asian-Americans: A Cross-Sectional Analysis

  2022cites this paper
• Personalized attention control therapy for PTSD: effectiveness and moderators of outcome in a randomized controlled trial

  2020cites this paper
• The Feasibility of a Parent Group Treatment for Youth with Anxiety Disorders and Obsessive Compulsive Disorder

  2020cites this paper
• Interprofessional care improves health-related well-being and reduces medical costs for chronic pain patients.

  2019cites this paper
• Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study

  2017cites this paper
• How to measure monetary losses in gambling disorder? An evidence-based refinement

  2017cites this paper
• S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.

  2017cites this paper
• Assessing Clinical Improvement in School-Based Treatment for Social Anxiety Disorder: Agreement Between Adolescents, Parents, and Independent Evaluators

  2017cites this paper
• Contributions to the development and validation of fMRI-based biomarkers for drug discovery in social anxiety disorder

  2016cites this paper
• Do Antidepressants Induce Psychosis in Children and Adolescents? A Naturalistic Study in Ambulatory Pediatric Population

  2016cites this paper
• Assessing Clinical Improvement in School-Based Treatment for Social Anxiety Disorder: Agreement Between Adolescents, Parents, and Independent Evaluators

  2016cites this paper
• Response to intravenous fentanyl infusion predicts subsequent response to transdermal fentanyl

  2016cites this paper
• Quality Measures for the Care of Patients with Insomnia

  2015cites this paper
• Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation

  2015cites this paper
• Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences.

  2015cites this paper
• Spiegeln sich die Konstrukte Selbstermächtigung und Behandlungszufriedenheit im psychiatrischen Funktionsniveau wider

  2015cites this paper
• Discrepancies in therapist and client ratings of global improvement following cognitive behavioral therapy for social phobia and their differential relations with symptom improvement at post-treatment and 12-month follow-up

  2014cites this paper
• Group therapy for anxiety in children with autism spectrum disorder

  2014cites this paper
• Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: initial validation of an imaging protocol for drug discovery.

  2014influential citation
• Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.

  2014influential citation
• Systematic Review of the Properties of Tools Used to Measure Outcomes in Anxiety Intervention Studies for Children with Autism Spectrum Disorders

  2014cites this paper
• A comparison of robotic walking therapy and conventional walking therapy in individuals with upper versus lower motor neuron lesions: a randomized controlled trial.

  2014cites this paper
• Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine.

  2013cites this paper
• Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment

  2012cites this paper
• The feasibility and safety of S-adenosyl-l-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial

  2012influential citation
• The clinical global impression scale and the influence of patient or staff perspective on outcome

  2011cites this paper
• Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials

  2011cites this paper
• A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment

  2011cites this paper
• subjects with age-associated memory impairment mg TC-1734 ( AZD 3480 ) with placebo , in older A randomized double-blind study comparing 25 and 50

  2011cites this paper
• The Psychopharmacology Algorithm Project at The Harvard South Shore Program: An Update on Generalized Social Anxiety Disorder

  2010cites this paper
• Effectiveness and Cost Offset Analysis of Group CBT for Hypochondriasis Delivered in a Psychiatric Setting: An Open Trial

  2010cites this paper